Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
|
|
|
51-200 employees
View all Shoreline Biosciences, Inc. employees
|
|
Biotechnology
|
|
La Jolla, CA 92037, US
|
|
2020
|
Kleanthis Gabriel Xanthopoulos is the CEO of Shoreline Biosciences, Inc.. To contact Kleanthis Gabriel Xanthopoulos email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.